HopeStage
Back to all studies
CompletedNCT01908205

Intranasal Oxytocin for Children and Adolescents With Autism

About this titleRead the official source — NCT01908205
Medication studyAges 10–17United States + CanadaAnxiety
The study in practice

Understand this study

Who was this study for?

Listed age limits: 10 years to 17 years.

Listed locations
Minneapolis and 1 more locationSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateSeptember 2013
Recruitment status
Completed
Enrollment listed in the registry
60
Sponsor
Holland Bloorview Kids Rehabilitation Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States, Canada
Age range
From 10 Years to 17 Years
Official registry ID
NCT01908205
Official title
Show the full official title

Intranasal Oxytocin for the Treatment of Children and Adolescents With Autism

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Minneapolis, United States · Toronto, Canada

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Holland Bloorview Kids Rehabilitation Hospital, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including Intranasal Oxytocin and Placebo.

Who was this study for?

Listed age limits: 10 years to 17 years.

Want to explore more studies?

Explore studies